Cellou Binani/AFP/Getty Images
In a small trial, an experimental vaccine protected 100 percent of people at high risk for Ebola. But more data are needed to figure out exactly how well the vaccine works. The study was published last week in the journal The Lancet.
Read more at NPR.org.